Amgen Inc at SunTrust Robinson Humphrey Life Sciences Summit Transcript

May 06, 2020 / 06:00PM GMT
Robyn Kay Shelton Karnauskas - SunTrust Robinson Humphrey, Inc., Research Division - Research Analyst

Hello, and welcome, everyone, to the SunTrust Robinson Humphrey live, virtually live life sciences summit. And it's my pleasure this morning to have from Amgen, David Reese, the Executive Vice President of R&D; and Arvind Sood, Vice President of Investor Relations. As a reminder, if you have questions that you'd like to ask management, please e-mail me at [email protected]. And before we begin, I have to read a disclosure statement, so bear with me.

This call has been arranged by SunTrust Robinson Humphrey research department for use by institutional investors as defined under FINRA rules as well as issuer clients in the firm. If you are not an institutional investor or issuer, please disconnect at this time. David Reese and Arvind Sood at Amgen, a biotech company, are not members of the SunTrust Robinson research department, and unless otherwise indicated, their views are their own and may differ from the views of SunTrust Robinson Humphrey research department and from views of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot